TELA Bio (TELA) Sales of Property, Plant and Equipment (2024 - 2026)

TELA Bio (TELA) Sales of Property, Plant and Equipment (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.51 Mn
10 TELA Bio 38.36 Mn -1.18 Mn 12.52 Mn 309,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 309,000.00
Mar 31, 2026 309,000.00
Dec 31, 2025 283,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 523,000.00
Sep 30, 2025 523,000.00
Jun 30, 2025 318,000.00
Jun 30, 2025 318,000.00
Mar 31, 2025 170,000.00
Mar 31, 2025 170,000.00
Dec 31, 2024 74,000.00
Dec 31, 2024 74,000.00
Jun 30, 2024 366,000.00
Jun 30, 2024 366,000.00
Mar 31, 2024 5.00 Mn
Mar 31, 2024 5.00 Mn